Ovid Therapeutics Inc (OVID)

$2.51 0.01 (0.40%)

5:17 EST OVID Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 61.80M

PE Ratio -1.41

EPS -1.777157

Volume (Avg. Vol.) 1,185

Day's Range 2.50 - 2.50

52-Week Range 1.80 - 9.40

Dividend & Yield N/A (N/A)

OVID Stock Predictions, Articles, and Ovid Therapeutics Inc News

From InvestorPlace
From the Web

Ovid Therapeutics News: Why OVID Stock Is Plunging 55% Today

By William White, InvestorPlace Writer Dec 2, 2020

Ovid Therapeutics (OVID) news for Wednesday concerning results from a recent clinical trial have OVID stock taking a beating.

4 Cheap Stocks to Invest in Today

By David Moadel, InvestorPlace Contributor Jun 11, 2020

When choosing cheap stocks to invest in you don't always have to sacrifice quality. Here are four high-quality companies that are affordable.

6 Cheap Stocks to Buy Under $7

By Maya Sasson, Writer, TipRanks Jan 15, 2020

No matter what, investors are always after returns. These six cheap stocks can make those returns a reality in 2020.

5 Strong Buy Stocks Under $5 With Massive Upside Potential

By Maya Sasson, Writer, TipRanks Dec 26, 2019

Snapping up strong buy stocks with great long-term growth prospects doesn’t have to cost you your entire savings.

10 Cheap Stocks to Buy Under $10

By Sarah Smith, InvestorPlace Web Content Producer Nov 13, 2019

These stocks come from a variety of industries, but all have positive catalysts in their futures. Buy these cheap stocks now while you can.

First Week of OVID March 19th Options Trading

From Market News Video Jan 15, 2021

Investors in Ovid Therapeutics Inc (OVID) saw new options begin trading this week, for the March 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OVID options chain for the new March 19th contracts and identified one put and one call contract of particular interest.

Interesting OVID Put And Call Options For February 2021

From Market News Video Dec 18, 2020

Investors in Ovid Therapeutics Inc (OVID) saw new options become available this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OVID options chain for the new February 2021 contracts and identified one put and one call contract of particular interest.

The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs

From Benzinga Dec 4, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 3) Atara Biotherapeutics Inc (...

70 Biggest Movers From Yesterday

From Benzinga Dec 4, 2020

Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 150% to close at $5.25 on Thursday after gaining 7% on Wednesday. The company released quarterly results...

54 Stocks Moving In Thursday's Mid-Day Session

From Benzinga Dec 3, 2020

Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares jumped 150% to $5.25 after gaining 7% on Wednesday. The company released quarterly results last month. Lizhi Inc...

62 Biggest Movers From Yesterday

From Benzinga Dec 3, 2020

Gainers Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares climbed 59.1% to close at $6.49 on Wednesday. Merrimack Pharmaceuticals, last month, reported a loss for the third...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold